Genome-wide association studies (GWAS) provide a means of examining the common genetic variation underlying a range of traits and disorders. In addition, it is hoped that GWAS may provide a means of differentiating affected from unaffected individuals. This has potential applications in the area of risk prediction. Current attempts to address this problem focus on using the polygene risk score (PRS) to predict case-control status on the basis of GWAS data.
Background
Genome-wide association studies (GWAS) capture common genetic variation in the form of single nucleotide polymorphisms (SNPs)and hence provide a means of investigating the genetic architecture of common heritable traits and disorders. In particular, the case-control GWAS, the most frequent GWAS design, has been used to identify systematic genetic differences between cases and unaffected controls in many complex disorders such as schizophrenia (SZ) [17] . One can also consider the inverse problem; that is, given the genetic profile of an individual, can we predict their case or control status? This has obvious applications in risk prediction in the clinical and public health areas even in the absence of a detailed understanding of the genetic mechanisms involved. But the classification problem is still a challenge. This is due to small effect sizes and the random variation of SNP allele frequencies as a result of finite sample sizes, as well as the polygenic nature of complex genetic disorders.
This classification problem has been addressed (in the context of GWAS) principally through the use of the polygenic risk score (PRS) ([20] , [8] , [10] ). For a PRS analysis, each individual in a test dataset is assigned a PRS which summarises their risk for the disorder or trait in question. The PRS is calculated by summing up the number of risk alleles the individual possesses for each SNP weighted by its effect size obtained from an independent training GWAS association analysis. The SNPs are all treated as independent. Examples are beginning to appear of the use of the PRS in a clinical setting. For example, the PRS has shown potential for screening individuals for breast cancer risk [13] but its clinical utility is currently limited [26] . For complex disorders such as SZ, the proportion of liability explained by the PRS is relatively low (about 7% for SZ, [17] ). Thus, the PRS on its own does not have the ability to discriminate effectively between affected and unaffected individuals [11] . In addition, standard independent testing of SNPs for association with traits is restrictive and does not allow for the possibility of identifying joint associations and interactions between SNPs.
In addition, it has been suggested that, due to the large number of SNPs used in the analysis, that (even after correction for population stratification) a significant fraction of the signal detected by the PRS is actually due to residual population effects [7] .
Genetic classification can be viewed as a pattern recognition problem; a class of problems for which artificial neural networks (ANNs) are particularly well suited. ANNs constitute a specific form of machine learning. The possibility of using machine learning methods for classification in genetics has been considered for over a decade (see, for example [18], [21],
[22] for some early reviews). More recently, attention has been drawn to the potential of deep learning, essentially a form of ANN using large numbers of hidden layers [27] . GWAS data present particular challenges for methods such as ANNs, in that the number of features (SNPS) is typically large in comparison with the number of training examples (sample size).
Early studies (see, for example [1] , [2] , [3] , [4] , [5] ), used small sample sizes (typically a few hundred samples) and in fact only a few tens of SNPs, although clinical covariates were typically included as well. The number of SNPs (9000) used in a recent study ( [6] ) was comparable to the number used in the work we report here but the sample size was still small (approximately 1800). Here we exploit the large sample sizes now available to investigate the potential of ANNs to predict disease risk on the basis of genetic data alone given a sufficient number of training examples. The use of genetic data alone potentially allows the prediction of risk before disease onset when clinical data are not yet available.
The specific dataset that we use is the SZ dataset from the Psychiatric Genomics Consortium (PGC), (containing approximately 64,000 samples), see Methods section.
Results

Sensitivity to Number of SNPs
The results of our analysis are shown in Fig 1 and Table 1 where we have varied the number of SNPs, for different sample sizes (10,000, 30,000, and 64,542). For each sample size we show the show the variation in performance for different p-value thresholds. Classification efficiency is measured as area under the curve (AUC). The ANN performs better than the PRS when small numbers of SNPs are used in the analysis. However, both methods become comparable as the number of SNPs increases for a given sample size (see Fig 1, plots (a), (b), (c)). Both methods show an improvement in performance that levels off as the number of SNPs increases beyond a certain point.
Sensitivity to Sample Size
Results for our sensitivity to sample size analysis can be seen in Fig 2 and 
Discussion
We have carried out analyses on the performance of an ANN and the PRS in classifying casecontrol status using GWAS schizophrenia data. We conducted sensitivity analyses with respect to both number of SNPs and sample size. Before discussing the results, we briefly review the differences between these two approaches to classification. In the PRS approach, an individual in a test dataset is assigned case or control status according to their risk score. The score is calculated by summing the number of risk alleles the individual possesses for each SNP weighted by its effect size. This effect size is obtained from an independent (training) dataset. The SNPs are treated as independent and the score is refined by increasing the number of SNPs in the analysis. The precision with which the effect size is estimated is improved by increasing the sample size in the training dataset. In the ANN, on the other hand, all SNPs are simultaneously taken into account for each sample. The network weights are adjusted accordingly, using the data from the training set and these weights are used to calculate probabilities of class membership in a test dataset. The probabilities are refined by increasing the sample size in the training dataset.
These two approaches are therefore complementary, and while we would expect the performance of both to increase with both sample size and number of SNPs, the behaviour of the two methods as these parameters vary will, in general, differ.
In our sensitivity to number of SNPs analysis (Fig 1, Table 1 ) the ANN initially performs better than the PRS. However, the PRS improves more quickly as the number of SNPs increases for a given sample size (see Fig 1, plots (a), (b), (c)). In both cases, the rate of improvement slows as the number of SNPs increases beyond a certain point. We have restricted the analysis to pvalue thresholds less than 0.05 (corresponding to approximately 16,000 SNPs for the largest sample size). This is partly for practical reasons (computation time for the ANN). It is also Table 1 ).
Note that the same p-value threshold at the larger sample sizes (for example, Fig 1, plot (c) in comparison to Fig 1 plot (a) ) implies an increase in the number of SNPs available for analysis. This means that we cannot make a definitive statement about the behavior of the methods as sample size increases on the basis of the SNP sensitivity analysis above. This issue is addressed explicitly in our second sensitivity analysis where the number of SNPs is kept approximately constant as we vary the sample size.
Results for our sensitivity to sample size analysis can be seen in Fig 2 and Table 2 where we have varied the sample size for three different sets of SNPs obtained from different p-value thresholds in a reference dataset. The maximum threshold used was 0.015 corresponding to approximately 3500 SNPs. The reason for this restriction was computation time for the ANN. It is likely that performance will improve further if a larger number of SNPs is used, however our objective here was to compare the behaviour of the two methods as sample size is varied, rather than to achieve optimum performance. Our results indicate a higher level of performance for the ANN relative to the PRS in 
Conclusions
there are two basic parameters that we can consider when we are carrying out this type of analysis: the number of SNPs and the sample size. We find that the performance of the PRS is more sensitive to the number of SNPS, while the ANN is more sensitive to the sample size.
We emphasize that the ANN architecture used here has been minimal (one hidden layer, two hidden nodes). In particular, the architecture has not been specifically optimised for this dataset and our results therefore have general validity. There is considerable scope for further development with regard to the optimisation of the architecture in order to further improve the ANN's performance on this dataset.
Performance in terms of computation time has also not been optimised (see Supporting
Information (SI) for details) since we do not regard this as a critical issue at this stage of development. Training times are therefore relatively long, in contrast to the PRS which requires only an association analysis on the training dataset to obtain the odds ratios required to compute the scores. Significant reductions in computation time should be achievable by optimisation of for example, step-size and (in particular) parallelisation.
An important issue for ANNs (and machine learning methods in general) is the dissemination of the results. (This is straightforward in the case of the PRS, since all that is required is the list of SNPs used and the associated odds ratios.) All the information for the trained network is available, in principle, in the list of SNPs and the list of network weights and biases; however this information is difficult to use and interpret in practice and it is desirable to have a complete end-to-end pipeline available. This is beyond the scope of the present work, but we plan to develop such a pipeline in the next phase of this project.
In summary, we have presented here an alternative potential approach to the current method of choice, the PRS for case-control classification. Our analysis indicates that the ANN outperforms the PRS at large sample sizes and will therefore prove a promising alternative to the PRS for the very large sample sizes that are now becoming available.
The results we have presented here are a proof-of-concept. Our ANN requires further optimisation to maximise performance. The system will also require further optimisation for speed in order to handle larger numbers of SNPs. In addition, a fully developed pipeline will be required in order for the system to be easily useable by the wide community. These issues will be addressed in the next phase of this work.
Methods
Data
We use the PGC SZ data (Ripke et al. [17] ). Of the total of 43 datasets analysed in [17] we have been granted access to 40, representing 84.1% of the total case-control data originally analysed (67,184 of 79,845 samples), (86.7% of the cases (29,689 of 34,241), 82.2% of the controls (37,495 of 45,604)). Each of these datasets has been imputed using the 1000 Genomes Project reference panel [19] and quality control (QC) has been applied to these individual datasets prior to our accessing the data. We use the datasets that have been subjected to a light QC (best guess genotypes based on imputation, SNP missing rate <2%) in order to maximise the overlap of SNPs between the datasets as we are performing a mega analysis rather than a meta-analysis. These datasets have approximately 7,000,000 variants each, see SI Table S1 . These data have been made available by the PGC, see Acknowledgements for details of how to access these data.
Data Quality Control, Filtering and Principal Component Analysis
We merged all 40 datasets using the PLINK 1.9 software [14] command -merge-list. This resulted in a dataset consisting of approximately 14,000,000 variants and 67,184 samples (29,689 cases, 37,495 controls). Next, non-SNP variants were removed, SNP missingness (>0.01) and individual missingness (>0.02) filtering was carried out, and related samples were removed (random removal of one individual from pairs of related samples with cases preferentially retained). Additional SNP QC was then carried out. This resulted in what we refer to as the Mega dataset consisting of approximately 2,000,000 variants (not all imputed SNPs were present in all 40 datasets). The dataset consisted of 64,542 samples (28,707 cases, 35,835 controls), see Table 3 . This Mega dataset was used as the basis for all subsequent analyses. In addition to filtering steps for SNPs and samples being carried out as part of the QC it was necessary to conduct principal component analyses (PCAs) in order to adjust association analyses for population stratification that is present in this merged dataset. For a PCA the dataset was pruned using Plink 1.9 [14] 
Artificial Neural Networks
In this section we briefly review the principles of artificial neural networks, as used for classification. An ANN consists of a number of interconnected neurons, or nodes, each of which processes information and passes it to other nodes in the network. There is an input layer which receives its inputs from the user and an output layer which delivers the outputs. In general, there will be one or more intermediate hidden layers; this is the architecture of the network (see Fig 3) . In the course of training, both inputs and outputs are specified and the ANN adjusts the network weights in order to achieve the best fit to the data. In this way the ANN learns to recognise patterns. In our application, the inputs are the SNP genotypes for each individual. There is a single output node -the probability of the case or control status of each individual.
The complexity of the behaviour of the ANN increases with the number of hidden nodes and hidden layers. Since in this study we are primarily interested in the general question of the performance of the ANN on large genetic datasets (and not on optimisation with respect to a particular disorder), we used a simple architecture with a single hidden layer consisting of two hidden nodes. The network is trained on a subset of the cases and controls. After training, the network is tested on an independent subset to assess its accuracy in predicting case/control status. We use the Skynet ANN for all analyses [9] . See SI for further details on the computational performance of this ANN.
Analysis Plan
All supervised learning classification problems incorporate two distinct steps. The first step, feature selection, involves determining the inputs that will be used to compute the classification. The second step, training, involves allocating appropriate weights to the selected features by using a training dataset in which both features and class labels are supplied. The trained classifier then uses these weights to classify new, previously unseen instances.
We begin by splitting the data into two non-overlapping subsets: training and test. The majority of the data (approximately 90%) is allocated to the training dataset. We perform additional SNP QC filtering (see Part 2, Table 3 ) independently on the training and test datasets. We conduct a PCA on the training dataset. We then carry out an association analysis correcting for PCs on the training dataset. We select SNPs (based on the association analysis and LD clumping in order to determine independent signals). These SNPs are the features for the classification step. For classification via the PRS the odds ratios (ORs) from the association analysis on the training dataset are supplied, as well as the SNP genotypes of the test dataset. We use the R statistical package PRSice [23] to compute the PRS. For classification in the ANN, the full genotype information for the selected SNPs for both the training and test datasets is required but not the ORs. This is the main difference in the information that is supplied to these classification methods. Based on the information that has been provided for the PRS a score is calculated for each sample in the test dataset which consists of the genotype data for the selected SNPs. In the case of the ANN the training genotypes are used to compute the network weights using the training data. These weights are then used to calculate class membership probabilities for each of the samples in the test dataset. See Figs S5-S8 in SI for details on the workflow. In order to examine the stability of the methods and to get error bounds we created ten independent training and test datasets as follows. We split the dataset into ten random disjoint subsets.
Each of these ten is used as a test dataset with its corresponding training dataset consisting of the other nine datasets combined. This ensures that all test datasets are independent of each other and each is independent of their associated training dataset.
Comparison of Performance
A standard method for assessing the performance of a classifier is the AUC and we employ this here. All AUCs are calculated in R [24] using the package pROC [25] .
Sensitivity to number of SNPs
The aim here is to compare the performance of both methods as we vary the number of SNPs. We examine the performance for three different sample sizes. We randomly select 10,000 (30,000 or use all of the Mega dataset) samples from the Mega dataset. We then split this dataset into ten disjoint subsets as described above. Each of these ten subsets is considered in turn as a test dataset with the remaining subsets its corresponding training dataset. This gives us ten replicates and enables us to compute a standard error (se) on the results. The ten test datasets are independent of each other by construction and each test dataset is also independent of its corresponding training dataset. For each replicate we carry out QC on the test and training dataset independently as described above. We then conduct an association analysis on the training dataset to obtain p-values for the SNPs. We then use these p-values to clump the SNPs at different levels of significance with results grouped based on LD (-clump command in plink). This ensures independence of the SNPs.
As the significance level increases the number of SNPs yielded also increases allowing us to examine the behavior of the methods as we vary the number of SNPs.
Sensitivity to Sample Size
The aim here is to compare the performance of both methods as we vary the number of samples. We examine the performance for three different p-value thresholds. In order to maintain approximately the same number of SNPs as we vary the sample size it is necessary to generate a reference set of SNPs from an independent subset of the Mega dataset. We randomly select 10,000 samples from the Mega dataset. We then conduct QC and PCA and an association analysis on this subset of data. We obtain three reference lists of SNPs at pvalue thresholds: 0.002, 0.005, and 0.015 and the resulting SNPs are also clumped to ensure independence of signals. These yield SNP sets of size 677, 1,411, and 3,608, respectively. We then use the remaining 54,542 samples of the Mega dataset to create ten disjoint subsets as described previous section. For each replicate we carry out QC on the test and training dataset independently as described above. We then conduct an association analysis on the training dataset. This provides the ORs necessary for the PRS. The SNPs to be used in the analysis are selected from the reference list. Note that not all SNPs in the reference list will be present due to QC, particularly at lower sample sizes, but these variations are small, see Table 2 . This allows us to examine the behavior of the methods as we vary the sample size using an approximately fixed number of SNPs.
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Computation
All calculations using the PGC data were carried out on the Lisa cluster which is part of the Dutch national e-infrastructure, where a repository of the data is maintained.
Computations were performed on the E5-2650 v2 nodes, each of which has 870Gb of scratch space, 64 Gb of memory, 20Mb of cache and clock speed 2.6 GHz. Each node supports 16 cores and up to 15 computations can be run simultaneously on each node. In practice, due to memory requirements at various points in the pipeline only one run at a time was carried out on a given node.
Approximate computation times on this hardware for the ANN (in serial mode) were as follows: At the lower end of the analyses described (sample size approximately 
